Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hypromellose; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 300 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; microcrystalline cellulose; hypromellose; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 450 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; silicon dioxide; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

European Union - English - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemic preparations - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

European Union - English - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemic preparations - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

corporate infinity company limited, tanzania - pads -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

quimetal industrial s.a. - sodium metabisulphate - slow release generator (inc. flea collars) - sodium metabisulphate ungrouped active 970.0 g/kg - fungicide - grapes (packaged) - botrytis | botrytis blight | bunch rot-grey mould | grey mould | grey mould (nesting) | storage rot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

e.e. muir & sons pty limited - sodium metabisulfite - slow release generator (inc. flea collars) - sodium metabisulfite mineral-sodium active 980.0 g/kg - fungicide - grapes (packaged) - botrytis | botrytis blight | bunch rot-grey mould | grey mould | grey mould (nesting) | storage rot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

quimetal industrial s.a. - sodium metabisulfite - slow release generator (inc. flea collars) - sodium metabisulfite mineral-sodium active 970.0 g/kg - fungicide - grapes (packaged) - botrytis | botrytis blight | bunch rot-grey mould | grey mould | grey mould (nesting) | storage rot

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are not to be used by patients with kidney disease.